Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
about
Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and MouseFusion of nonclinical and clinical data to predict human drug safety.Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study.Acute cardiotoxicity evaluation of the marine biotoxins OA, DTX-1 and YTXEVALUATION OF THE ACUTE AND SUBCHRONIC TOXICITY OF Aster tataricus L. F.Human resistin in chemotherapy-induced heart failure in humanized male mice and in women treated for breast cancer.Serum biomarkers reveal long-term cardiac injury in isoproterenol-treated African green monkeys.Acute and Subchronic Toxic Effects of the Fruits of Physalis peruviana L.Nutrigenomic effects of glucosinolates on liver, muscle and distal kidney in parasite-free and salmon louse infected Atlantic salmon.Ventricular Parasystole in a Neonatal Rhesus Macaque (Macaca mulatta).In vivo arrhythmogenicity of the marine biotoxin azaspiracid-2 in rats.Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury.Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy.Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories.Troponin as a biomarker of cardiac toxicity: past, present, and future.MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.Evaluation of azithromycin induced cardiotoxicity in rats.Heart-type fatty acid-binding protein and its relation with morphological changes in rat myocardial damage model induced by isoproterenol.Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat.The Toxicity of Soman in the African Green Monkey (Chlorocebus aethiops).Lipid Emulsion Inhibits Apoptosis Induced by a Toxic Dose of Verapamil via the Delta-Opioid Receptor in H9c2 Rat Cardiomyoblasts.Spontaneous cardiomyopathy in young Sprague-Dawley rats: evaluation of biological and environmental variability.Refinement of tourniquet-induced peripheral ischemia/reperfusion injury in rats: comparison of 2 h vs 24 h reperfusion.Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes.Characterization of troponin responses in isoproterenol-induced cardiac injury in the Hanover Wistar rat.The effects of heart and skeletal muscle inflammation and cardiomyopathy syndrome on creatine kinase and lactate dehydrogenase levels in Atlantic salmon (Salmo salar L.)
P2860
Q28079801-F61D3305-4E67-4104-AF65-C6503233CE10Q34615323-C3A3158F-9B15-4719-B699-F31B072187C4Q35088064-5EB3E224-60F8-4582-A1E5-676E8E9BC991Q35564017-B1CD0534-67B7-4C86-B52F-714CCCAA273AQ36365406-4E7BA83C-3F9D-4CFF-86AD-F3B9F52C0B84Q37240194-9816A6BD-BD7C-4111-BF52-29389269B725Q37266056-8CFAFA11-44D0-4B0D-AC0C-412D8C8C058EQ37393173-132CCDD1-25F5-4838-9C90-5571AA1D2D22Q37497682-AB6F7DBB-98BD-40A6-8566-A099A22993DAQ37505899-018FB418-0F4F-4626-A1BF-38B808EE8BE8Q37624888-570198B1-A5A6-4C8C-BAAF-7C0073C0F6D7Q38166071-46C032AF-7201-4FBE-AD2B-40B97495F554Q38302852-37602979-F96E-429F-AAE8-67E9A8D1ECB9Q39379692-BA16977B-1E02-4546-84FA-682B70EC135FQ39832027-67D61CD8-6563-4DEE-AAA3-3206F8A1203EQ40026732-120BEFF8-43ED-4CAC-9ADA-384F6CE1AEB6Q41043981-2C2C57B3-F48F-4F08-9BE0-81D076AF1CBCQ41956187-7DD1F90A-11FF-4B52-8383-8A0E7F7605BAQ43002912-CBE2DF19-C36C-4A26-BF8B-FA422B3E5A5AQ43215818-56306AE8-8FEF-4C8A-B8E5-0D149F0A8367Q44342087-269DA1E0-5B85-4460-B85F-2405765E648CQ46753697-33982719-C00F-4803-9FED-852FE8660646Q47904887-9DD8781A-9DFE-40E7-AEF6-E1860807286BQ48353831-0F6D43F0-DE36-4E9C-A94E-E0B7864C5FC2Q51744835-F46F51F3-97AF-437C-996F-0098F21BC7B4Q58915023-49617460-C50F-462E-BC15-4D8D76A7ECC4
P2860
Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
@ast
Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
@en
type
label
Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
@ast
Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
@en
prefLabel
Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
@ast
Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
@en
P2860
P1476
Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
@en
P2093
Dana B Walker
P2860
P304
P356
10.1080/01926230500519816
P407
P577
2006-01-01T00:00:00Z